share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay

SEC announcement ·  Jan 31 16:29
Summary by Moomoo AI
Virpax Pharmaceuticals Inc. (VRPX) reported a transaction involving Shah Vinay, the company's Chief Financial Officer. The transaction took place on January 29, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Shah Vinay after the transaction was not provided. Investors are advised to note the involvement of a key executive in the transaction, which could be indicative of the company's financial maneuvers.
Virpax Pharmaceuticals Inc. (VRPX) reported a transaction involving Shah Vinay, the company's Chief Financial Officer. The transaction took place on January 29, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Shah Vinay after the transaction was not provided. Investors are advised to note the involvement of a key executive in the transaction, which could be indicative of the company's financial maneuvers.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more